Canopy Growth (CGC) Revenue Growth (5y) (2024 - 2025)
Canopy Growth (CGC) Revenue Growth (5y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | Canopy Growth | 278.31 Mn | 12.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.92% |
| Sep 30, 2025 | -13.75% |
| Jun 30, 2025 | -9.53% |
| Dec 31, 2024 | -10.61% |
| Sep 30, 2024 | -4.47% |
| Jun 30, 2024 | -6.47% |
| Mar 31, 2024 | -5.25% |